856
Views
14
CrossRef citations to date
0
Altmetric
Review Articles

Non-invasive ventilation in amyotrophic lateral sclerosis

, , , , &
Pages 85-95 | Received 12 Jun 2012, Accepted 28 Oct 2012, Published online: 04 Jan 2013

References

  • Andersen P, Abrahams S, Borasio G, de Carvalho M, Chio A, van Damme P, . EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012:19;360–75.
  • Langevin B, Petitjean T, Philit F, Robert D. Nocturnal hypoventilation in chronic respiratory failure (CRF) due to neuromuscular disease. Sleep. 2000;23:S204–8.
  • Piper A. Nocturnal hypoventilation: identifying and treating syndromes. Indian J Med Res. 2010;131:350–65.
  • Krieger J. Respiratory physiology: breathing in normal subjects. In: Kryger M, Roth T, Dement W. Principles and Practice of Sleep Medicine. 3rd edn. Philadelphia: W. Saunders; 2000. pp 229–53.
  • Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33–7.
  • del Aguila M, Longstreth W, McGuire V, Koepsell T, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
  • Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler. 2004;5;208–12.
  • Fujimura-Kiyono C, Kimura F, Ishida S, Nakajima H, Hosokawa T, Sugino M, . Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1244–9.
  • Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana M, . Early symptom progression rate is related to ALS outcome: a prospective population based study. Neurology. 2002;59:99–103.
  • Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population based registry. Neuroepidemiology. 2005;25: 114–9.
  • Czaplinski A, Yen A, Appel S. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006;253: 1428–36.
  • Thijs V, Peeters E, Theys P, Matthijs G, Robberecht W. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg. 2000;100:84–90.
  • Beghi E, Millul A, Logroscino G, Vitelli E, Micheli A. Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008;9:163–7.
  • Tysnes O, Vollset S, Larsen J, Aarli J. Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology. 1994;13:226–35.
  • Louwerse E, Visser C, Bossuyt P, Weverling G. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci. 1997;152:S10–7.
  • Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J. ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler. 2010;11:379–82.
  • Shoesmith C, Findlater K, Rowe A, Strong M. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry. 2007;78:629–31.
  • Baumann F, Henderson R, Morrison S, Brown M, Hutchinson N, Douglas J, . Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194–202.
  • Kaufmann P, Levy G, Thompson J, Delbene M, Battista V, Gordon P, . The ALSFRS-R predicts survival time in an ALS clinic population. Neurology. 2005;64:38–43.
  • Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophyiol. 2012: Epub ahead of print.
  • Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS progression. J Neurol Sci. 2008;275: 69–73.
  • Louwerse E, Visser C, Bossuyt P, Weverling G. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium. J Neurol Sci. 1997;152:S10–7.
  • Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66: 265–7.
  • Velasco R, Salachas F, Munerati E, Le Forestier N, Pradat P, Lacomblez L, . Nocturnal oximetry in patients with amyotrophic lateral sclerosis: role in predicting survival. Rev Neurol. 2002;158:575–8.
  • Olney R, Murphy J, Forshew D, Garwood E, Miller B, Langmore S, . The effects of executive and behavioural dysfunction on the course of ALS. Neurology. 2005;65:1774–7.
  • Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Predictors of long survival in amyotrophic lateral sclerosis: a population based study. J Neurol Sci. 2008;268:28–32.
  • McDonald E, Wiedenfeld S, Hillel A, Carpenter C, Walter R. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Arch Neurol. 1994;51:17–23.
  • Desport J, Preux P, Truong T, Vallat J, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53:1059–63.
  • Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585–91.
  • Lacomblez L, Bensimon G, Leigh P, Guillet P, Powe L, Durrleman S, . A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 1996;47:S242–50.
  • Traynor B, Alexander M, Corr B, Frost E, Hardiman O. An outcome study of riluzole in amyotrophic lateral sclerosis: a population based study in Ireland, 1996 − 2000. J Neurol. 2003;250:473–9.
  • Traynor B, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996 − 000. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
  • Bach J. Amyotrophic lateral sclerosis. Communication status and survival with ventilator support. Am J Phys Med Rehabil. 1993;72:343–9.
  • Sridhar M, Anderson K, Weir A, Moran F, Banham S. Diaphragmatic paralysis in motor neuron disease: use of non-invasive investigative and therapeutic techniques. Br J Clin Pract. 1994;48:156–7.
  • Simonds A, Elliot M. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax. 1995;50:604–9.
  • Cazzolli P, Oppenheimer E. Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared dot tracheostomy-intermittent positive pressure ventilation. J Neurol Sci. 1996;139:123–8.
  • Escarrabill J, Estopá R, Farrero E, Monasterio C, Manresa F. Long-term mechanical ventilation in amyotrophic lateral sclerosis. Respir Med. 1998;92:438–41.
  • Pinto A, Evangelista T, Carvalho M, Alves M, Sales Luis M. Respiratory assistance with a non-invasive ventilator (BiPAP) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 1995;129:S19−26.
  • Bach J. Amyotrophic lateral sclerosis. Prolongation of life by non-invasive respiratory aids. Chest. 2002;122:92–8.
  • Radunovic A, Annane D, Jewitt K, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2009;4:CD004427.
  • Bourke S, Tomlinson M, Williams T, Bullock R, Shaw P, Gibson G. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol. 2006;5: 140–7.
  • Sivori M, Rodriguez G, Pascansky D, Saenz C, Sica R. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole. Medicina. 2007;67:326–30.
  • Corcia P, Meininger V. Management of amyotrophic lateral sclerosis. Drugs. 2008;68:1037–48.
  • Simmons Z, Bremer B, Robbins R, Walsh S, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92.
  • Robbins R, Simmons Z, Bremer B, Walsh S, Fischer S. Quality of life in ALS is maintained as physical function declines. Neurology. 2001;56:442–4.
  • Roach A, Averill A, Segerstrom S, Kasarskis E. The dynamics of quality of life in ALS patients and caregivers. Ann Behav Med. 2009;37:197–206.
  • Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H. Depression and QoL in patients with ALS: how do self-ratings and ratings by relatives differ?Qual Life Res. 2011;20: 569–74.
  • Lou J, Moore D, Gordon P, Miller R. Correlates of quality of life in ALS: lessons from the minocylcline study. Amyotroph Lateral Scler. 2010;11:116–21.
  • Bourke S, Shaw P, Gibson G. Respiratory function vs. sleep-disordered breathing as predictors of QoL in ALS. Neurology. 2001;57:2040–4.
  • Young J, Marshall C, Anderson E. Amyotrophic lateral sclerosis patients’ perspectives on use of mechanical ventilation. Health Soc Work. 1994;19:253–60.
  • Lemoignan J, Ells C. Amyotrophic lateral sclerosis and assisted ventilation: how patients decide. Palliat Support Care. 2010;8:207–13.
  • Zamietra K, Lehman E, Felgoise S, Walsh S, Stephens H, Simmons Z. Non-invasive ventilation and gastrostomy may not impact overall quality of life in patients with ALS. Amyotroph Lateral Scler. 2012;13:55–8.
  • Kaub-Wittemer D, von Steinbüchel N, Wasner M, Laier-Groeneveld G, Borasio G. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003; 26:890–6.
  • Mustfa N, Walsh E, Bryant V, Lyall R, Addington-Hall J, Goldstein L, . The effect of non-invasive ventilation on ALS patients and their caregivers. Neurology. 2006;66: 1211–7.
  • McKim D, King J, Walker K, Leblanc C, Timpson D, Wilson K, . Formal ventilation patient education for ALS predicts real-life choices. Amyotroph Lateral Scler. 2012; 13:59–65.
  • Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V. Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011; 82:839–42.
  • Arnulf I, Similowski T, Salachas F, Garma L, Mehiri S, Attali V, . Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2000;161:849–56.
  • Atalaia A, de Carvalho M, Evangelista T, Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotroph Lateral Scler. 2007;8:101–5.
  • de Carvalho M, Cost J, Pinto S, Pinto A. Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation. Amyotroph Lateral Scler. 2009;10:154–61.
  • Kimura K, Tachibana N, Kimura J, Shibasaki H. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis. J Neurol Sci. 1999;164:37–43.
  • Ferguson K, Strong M, Ahmad D, George C. Sleep-disordered breathing in amyotrophic lateral sclerosis. Chest. 1996;110:664–9.
  • Carratu P, Cassano A, Gadaleta F, Tedone M, Dongiovanni S, Fanfulla F, . Association between low sniff nasal-inspiratory pressure (SNIP) and sleep disordered breathing in amyotrophic lateral sclerosis: preliminary results. Amyotroph Lateral Scler. 2011;12:458–63.
  • Lyall R, Donaldson N, Fleming T, Wood C, Newsom-Davis I, Polkey M, . A prospective study of quality of life in ALS patients treated with non-invasive ventilation. Neurology. 2001;57:153–6.
  • Bourke S, Bullock R, Williams T, Shaw P, Gibson G. Non-invasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61:171–7.
  • Butz M, Wollinsky K, Wiedemuth-Catrinescu U, Sperfeld A, Winter S, Mehrkens H, . Longitudinal effects of non-invasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003; 82:597–604.
  • Gonzalez-Bermejo J, Morélot-Panzini C, Salachas F, Redolfi S, Straus C, Becquemin M, . Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:44–54.
  • Amirjani N, Kiernan M, McKenzie D, Butler J, Gandevia S. Is there a case for diaphragm pacing for amyotrophic lateral sclerosis patients?Amyotroph Lateral Scler. 2012: Epub ahead of print.
  • Atkeson A, RoyChoudhury A, Harrington-Moroney G, Shah B, Mitsumoto H, Basner R. Patient-ventilator asynchrony with nocturnal non-invasive ventilation in ALS. Neurology. 2011;77:549–55.
  • Fallat R, Jewitt B, Bass M, Kamm B, Norris F. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:74–80.
  • Melo J, Homma A, Iturriaga E, Frierson L, Amato A, Anzueto A, . Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicentre survey and proposal of a pulmonary protocol. J Neurol Sci. 1999;169:114–7.
  • Schiffman P, Belsh J. Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest. 1993;103:508–13.
  • Lechtzin N, Scott Y, Busse A, Clawson L, Kimball R, Wiener C. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler. 2007;8:185–8.
  • Varrato J, Siderowf A, Damiano P, Gregory S, Feinberg D, McCluskey L. Postural change of forced vital capacity predicts some respiratory symptoms in ALS. Neurology. 2001;57:357–9.
  • Elman L, Siderowf A, McCluskey L. Nocturnal oximetry. Utility in the respiratory management of amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82:866–70.
  • Misuri G, Lanini B, Gigliotti F, Iandelli I, Pizzi A, Bertolini M, . Mechanism of CO2 retention in patients with neuromuscular disease. Chest. 2000;117:447–53.
  • Mendoza M, Gelinas D, Moore D, Miller R. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007; 8:106–11.
  • Lyall R, Donaldson N, Polkey M, Leigh P, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
  • Morgan R, McNally S, Alexander M, Conroy R, Hardiman O, Costello R. Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269–74.
  • Bauer M, Czell D, Hartmann S, Goldman B, Müller D, Weber M. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial. Respiration. 2012; Epub ahead of print.
  • Pinto S, Turkman A, Pinto A, Swash M, de Carvalho M. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies. Clin Neurophysiol. 2009;120:941–6.
  • Jackson C, Rosenfeld J, Moore D, Bryan W, Barohn R, Wrench M, . A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci. 2001; 191:75–8.
  • Pinto A, de Carvalho M, Evangelista T, Lopes A, Sales-Luis L. Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:31–5.
  • Kim S, Park K, Nam H, Ahn S, Kim S, Sung J, . Capnography for assessing nocturnal hypoventilation and predicting compliance with subsequent non-invasive ventilation in patients with ALS. PLoS One. 2011;6:e17893.
  • Rafiq M, Bradburn M, Proctor A, Billings C, Bianchi S, McDermott C, . Using transcutaneous carbon dioxide monitor (TOSCA 500) to detect respiratory failure in patients with amyotrophic lateral sclerosis: a validation study. Amyotroph Lateral Scler. 2012;Epub ahead of print.
  • Leonardis L, Dolenc Grošelj L, Vidmar G. Factors related to respiration influencing survival and respiratory function in patients with amyotrophic lateral sclerosis: a retrospective study. Eur J Neurol. 2012; Epub ahead of print.
  • Kleopa K, Sherman M, Neal B, Romano G, Heiman-Patterson T. BiPAP improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999; 164:82–8.
  • Aboussouan L, Khan S, Banerjee M, Arroliga A, Mitsumoto H. Objective measures of the efficacy of non-invasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:403–9.
  • Lo Coco D, Marches S, Pesco M, La Bella V, Piccoli F, Lo Coco A. Non-invasive positive-pressure ventilation in ALS: predictors of tolerance and survival. Neurology. 2006;67: 761–5.
  • Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, . Non-invasive ventilation in amyotrophic lateral sclerosis: a 10-year population based study. J Neurol Neurosurg Psychiatry. 2011;83:377–81.
  • Jackson C, Lovitt S, Gowda N, Anderson F, Miller R. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler. 2006;7:80–5.
  • Gruis K, Brown D, Schoennemann A, Zebarah V, Feldman E. Predictors of non-invasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2005;32:808–11.
  • Volanti P, Cibella F, Sarva M, de Cicco D, Spaneveloo A, Mora G, . Predictors of non-invasive ventilation tolerance in amyotrophic lateral sclerosis. J Neurol Sci. 2011;303: 114–8.
  • Pinto S, de Carvalho M. Is a four-hour use of non-invasive ventilation enough to define compliance?Amyotroph Lateral Scler. 2010;11:250–2.
  • Pinto A, Almeida J, Pinto S, Pereira J, Oliveira A, de Carvalho M. Home telemonitoring of non-invasive ventilation decreases healthcare utilization in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010;81:1238–42.
  • Bach J, Saporito L. Criteria for extubation and tracheostomy tube removal for patients with ventilator failure: a different approach to weaning. Chest. 1996;110: 1566–71.
  • Bach J, Ishikama Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997;112:1024–8.
  • Mustfa N, Aiello M, Lyall R, Nikoletou D, Olivieri D, Leigh P, . Cough augmentation in amyotrophic lateral sclerosis. Neurology. 2003;61:1285–7.
  • Vitacca M, Paneroni M, Trainini D, Bianchi L, Assoni G, Saleri M, . At-home and on-demand mechanical cough assistance programme for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2010;89: 401–6.
  • Sancho J, Servera E, Diaz J, Marin J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004;125: 1400–5.
  • Senent C, Golmard J, Salachas F, Chiner E, Morelot-Panzini C, Meninger V, . A comparison of assisted cough techniques in stable patients with severe respiratory insufficiency due to amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:26–32.
  • Winck J, Goncalves M, Lourenco C, Viana P, Almeida J, Bach J. Effects of mechanical insufflation-exsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest. 2004;126:774–8.
  • Kim D, Kang S, Park Y, Choi W, Lee H. Artificial external glottic device for passive lung insufflation. Yonsei Med J. 2011;52:972–6.
  • Bach J, Mahajan K, Lipa B, Saporito L, Goncalves M, Komaroff E. Lung insufflation capacity in neuromuscular disease. Am J Phys Med Rehabil. 2008;87:720–5.
  • Wright C. Minitracheostomy. Clin Chest Med. 2003; 24:431–5.
  • Haverkamp L, Appel V, Appel S. Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
  • Oliver D. The quality of care and symptom control: the effects on the terminal phase of ALS/MND. J Neurol Sci. 1996;139:134–6.
  • Hadjikoutis S, Wiles C. Respiratory complications related to bulbar dysfunction in motor neuron disease. Acta Neurol Scan. 2001;103:207–13.
  • Yang R, Huang R, Chen D, Song W, Zeng Y, Zhao B, . Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler. 2011;12:206–9.
  • Spataro R, Lo Re M, Piccoli T, Piccoli F, La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand. 2010;122:217–23.
  • Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, . Causes of death among French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
  • Farrero E, Prats E, Povedano M, Martinez-Matos J, Manresa F, Escarrabill J. Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. Chest. 2005;127:2132–8.
  • Chio A, Calvo A, Moglia C, Gamna F, Mattei A, Mazzini L, . Non-invasive ventilation in amyotrophic lateral sclerosis: a 10-year population based study. J Neurol Neurosurg Psychiatry. 2012;83:377–81.
  • de Vito E, Suarez A, Monteiro S. The use of full-setting non-invasive ventilation in the home care of people with amyotrophic lateral sclerosis/motor neuron disease with end-stage respiratory muscle fatigue: a case series. J Med Case Rep. 2012;6:42.
  • Andersen P, Borasio G, Dengler R, Hardiman O, Kollewe K, Leigh P, . Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler. 2007;8: 195–213.
  • Miller R, Rosenberg J, Gelinas D, Mitsumoto H, Newman D, Sufit R, . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23.
  • Bach J, Bianchi C, Aufiero E. Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest. 2004; 126:1502–7.
  • Borasio G, Gelinas D, Yanagisawa N. Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol. 1998; 245:S7–12.
  • Tollefsen E, Midgren B, Bakke P, Fondenes O. Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation. Eur J Neurol. 2010;17:1352–7.
  • Ritsma B, Berger M, Charland D, Khoury M, Phillips J, Quon M, . NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. Can J Neurol Sci. 2010;37:54–60.
  • Sancho J, Servera E, Diaz J, Banuls P, Marin J. Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and one-year survival. Thorax. 2011;66:948–52.
  • Rousseau M, Pietra S, Blaya J, Catala A. Quality of life of ALS and LIS patients with and without invasive mechanical ventilation. J Neurol. 2011;2578:1801–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.